Emerging non-antibody‒drug conjugates (non-ADCs) therapeutics of toxins for cancer treatment
The non-selective cytotoxicity of toxins limits the clinical relevance of the toxins. In recent years, toxins have been widely used as warheads for antibody‒drug conjugates (ADCs) due to their efficient killing activity against various cancer cells. Although ADCs confer certain targeting properties...
| Hlavní autoři: | , , , , , , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Elsevier
2024-04-01
|
| Edice: | Acta Pharmaceutica Sinica B |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2211383523004525 |